P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection

P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection

Bibliographic Details
Main Authors: Frahm N, Noonan L, DeFawe O, Casimiro D, Simandl J, Spies G, McElrath MJ
Format: Article
Language:English
Published: BMC 2009-10-01
Series:Retrovirology
id doaj-3e494c4f556349f389964167e918c4fd
record_format Article
spelling doaj-3e494c4f556349f389964167e918c4fd2020-11-25T00:44:52ZengBMCRetrovirology1742-46902009-10-016Suppl 3P36810.1186/1742-4690-6-S3-P368P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infectionFrahm NNoonan LDeFawe OCasimiro DSimandl JSpies GMcElrath MJ
collection DOAJ
language English
format Article
sources DOAJ
author Frahm N
Noonan L
DeFawe O
Casimiro D
Simandl J
Spies G
McElrath MJ
spellingShingle Frahm N
Noonan L
DeFawe O
Casimiro D
Simandl J
Spies G
McElrath MJ
P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection
Retrovirology
author_facet Frahm N
Noonan L
DeFawe O
Casimiro D
Simandl J
Spies G
McElrath MJ
author_sort Frahm N
title P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection
title_short P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection
title_full P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection
title_fullStr P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection
title_full_unstemmed P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection
title_sort p19-48. induction of ad5 neutralizing antibodies in placebo recipients during the step trial is not associated with risk of hiv infection
publisher BMC
series Retrovirology
issn 1742-4690
publishDate 2009-10-01
work_keys_str_mv AT frahmn p1948inductionofad5neutralizingantibodiesinplaceborecipientsduringthesteptrialisnotassociatedwithriskofhivinfection
AT noonanl p1948inductionofad5neutralizingantibodiesinplaceborecipientsduringthesteptrialisnotassociatedwithriskofhivinfection
AT defaweo p1948inductionofad5neutralizingantibodiesinplaceborecipientsduringthesteptrialisnotassociatedwithriskofhivinfection
AT casimirod p1948inductionofad5neutralizingantibodiesinplaceborecipientsduringthesteptrialisnotassociatedwithriskofhivinfection
AT simandlj p1948inductionofad5neutralizingantibodiesinplaceborecipientsduringthesteptrialisnotassociatedwithriskofhivinfection
AT spiesg p1948inductionofad5neutralizingantibodiesinplaceborecipientsduringthesteptrialisnotassociatedwithriskofhivinfection
AT mcelrathmj p1948inductionofad5neutralizingantibodiesinplaceborecipientsduringthesteptrialisnotassociatedwithriskofhivinfection
_version_ 1725272784531095552

Similar Items